Coccidiosis of chickens, caused by species of Eimeria (Protozoa, Apicomplexa), is an intestinal disease of major economic importance worldwide. In the present study, the reproductive characteristics of a precocious line (designated E. tenella Rt3+15) from Australia were investigated in chicken embryos and the implications of the findings briefly discussed.
Coccidiosis of chickens is an intestinal disease of major economic importance globally and is caused by one or more of seven species of Eimeria (Apicomplexa, Eimeriidae). Eimeria tenella is the most pathogenic species, causing haemorrhagic typhlitis in chickens (McDougald and Reid 1997) . Eimeria species reproduce asexually (schizogony or merogony) and sexually (gametogony) in the intestinal cells to produce large numbers of progeny (oocysts), which are excreted in the faeces and subsequently undergo sporulation (sporogony) in the environment to become infective to susceptible chickens (McDougald and Reid 1997) .
The ability to complete the life cycle of various species of Eimeria in embryonated chicken eggs has significant implications for investigating fundamental aspects of their biology and development, for establishing methods for the testing of anti-coccidial drugs and for the production of live vaccines against avian coccidiosis. Long (1965, 1966) first demonstrated that some species of Eimeria could complete their endogenous development in the chorioallantoic membrane of the chicken embryo. Subsequently, Long (1972 Long ( , 1973 also showed that the continuous passage of E. tenella in embryos resulted in an adaptation, associated with a reduction of pathogenicity, size of the schizonts (asexual stages) and a change in the site of development, compared with the original, 'parent' line of the parasite. Serial passage of E. tenella in embryonating chicken eggs usually results in the development of a line of parasite which is significantly less pathogenic to chickens compared with wild-type strains while remaining immunogenic (Long et al. 1982) . For these reasons, an egg-adapted line of E. tenella (derived after >100 passages) has been included in a commercial vaccine (Livacox ® ) (Shirley and Bedrnik 1997; Williams 2002a, b) . Recently, a live vaccine, Eimeriavax ® , with multiple species of Eimeria, containing a precocious line (for definition see Shirley and Bedrnik 1997) of E. tenella, was developed and has been released in Australia (http://www.apvma.gov.au/gazette/gazette0302p17.shtml). In the present study, the reproductive characteristics of this 'precocious' line (designated E. tenella Rt3+15) were investigated in chicken embryos and the implications of the findings discussed.
A precocious line (Rt3+15) of E. tenella originally isolated from naturally infected chickens in Australia and produced according to an approach described by Shirley and Bedrnik (1997) was maintained in specific pathogen-free (SPF) chickens, held in custom-built isolators under stringent conditions to prevent cross-contamination. The parent line of E. tenella was originally identified to species based on the morphometry of sporulated oocysts, prepatent period and location of gross lesions in the caeca (McDougald and Reid 1997) . The biological parameters of the precocious line Rt3+15 conformed to those (i.e. shortened prepatent period, smaller and fewer generations in schizogony, lower virulence Skóra Stefañski DOI: 10.2478/s11686-006-0024-6and reproductive potential) defined by Bedrnik et al. (1995) , and the monospecificity of this line was verified by molecular analysis (Woods et al. 2000) .
Oocysts produced in SPF chickens were allowed to sporulate in the caecal content under constant aeration at 30°C for a minimum of 48 h, isolated by flotation using saturated NaCl, washed extensively in water, pelleted by centrifugation (1,000 × g for 10 min) and resuspended and stored in phosphatebuffered saline (PBS) supplemented with benzyl-penicillin (200 IU) and dihydro-streptomycin sulphate (250 mg/ml) at a concentration of 10 4 oocysts per ml (estimated using a Neubauer haemocytometer; Gasser et al. 1987) . Approximately 10 5 oocysts were washed three times in PBS (by centrifugation) in a tube and then resuspended in 3.3 ml of PBS; a subaliquot (300 µl) of oocyst suspension was plated on horse blood agar (Oxoid ® ) and incubated aerobically at 37°C for 24 h to examine whether any bacteria were capable of growing (after exposure to antibiotics). The same volume (3 ml) of glass beads (2 mm in diameter) was added to the tube which was vortexed for 2 min until >90% of the oocysts had ruptured to release sporocysts (verified by light microscopic examination at ×100 magnification). To release sporozoites from the sporocysts, the suspension (without glass beads) was transferred to a fresh conical 50 ml tube and incubated (under gentle inversion every 20 min) at 41°C for 60-90 min in 25 ml of PBS containing 1% w/v porcine trypsin and 2% w/v sodium taurocholate (Sigma). The tube was centrifuged, the supernatant aspirated and 50 ml of foetal calf serum (FCS) containing antibiotics (same concentration as used previously) added. The sporozoites were sedimented by centrigation and resuspended in 50% v/v FCS in PBS to achieve a final concentration of 5 × 10 4 per ml. This suspension, preincubated at 41°C, was used for the inoculation of embryonating chicken eggs.
Fertile eggs from SPF chickens incubated to produce 10-day-old embryos were used for the inoculation with different doses of sporozoites (Table I ). The eggs were candled, the air sac marked, and a site free from blood vessels selected for the inoculation. The injection site on the shell was disinfected with iodine, allowed to dry, and a small hole (2 mm; above the air sac) drilled into which a circular dentist drill prick punch was inserted. The sporozoite suspension was then injected into the allantoic cavity using a sterile 25-gauge needle. The hole was sealed with a non-toxic glue, and the eggs incubated at 38°C for 4 h (rotating them every 30 min) and subsequently at 41°C for 7 days (rotating them two times daily). Within 24 h of inoculation, the eggs were candled to verify the viability of the embryos, and daily thereafter.
After 168 h, eggs were cooled to 4°C and the shell over the air sac was fractured and removed to the level of the air sac/allantoic cavity region using sterile forceps. The membrane separating the air sac from the embryo was peeled off. The embryo was removed with the yolk sac and albumen bolus, and the allantoic fluid discarded. The remaining chorioallantoic membranes (with meconium and urate deposits) were excised and placed into a sterile container. The membranes were pooled, diced finely using scissors, placed into a 50 ml tube and centrifuged at 2,000 g for 15 min. The membranes were washed in PBS, followed by two washes in PBS containing 2% Tergitol ® (BDH Chemicals). They were then transferred to a fresh tube, digested for 60 min in 1% trypsin (in PBS) and centrifuged at 2,000 g for 10 min. The supernatant was discarded and the sediment resuspended in 1% v/v potassium dichromate (in 30-40 ml). The remaining tissue residues were removed by sieving (1 mm mesh size). Oocysts were allowed to sporulate (at 30°C under constant aeration)
for $48 h, after which sporulation was verified microscopically. The sporulated oocysts were sedimented, washed two times in 40 ml of water, incubated for 20 min with 3% v/v sodium hypochlorite, washed extensively in PBS containing antibiotics (at the same concentration as used previously) and stored at 4°C. The oocysts in the suspension were enumerated, and the sporulation established (see Table I ).
After preliminary experiments, in which it was shown that the precocious vaccine line (Rt3+15) of E. tenella could be propagated in chicken embryos, seven independent experi-157 OEl¹ski Table I . Using inoculation doses of 2,600-8,700 sporozoites per egg, 16,000 -360,000 oocysts were produced per egg. The oocyst yields equated to reproductive indices varying from 17-577. The mortality of infected chicken embryos ranged from 3.7-25.4%. There was no evidence of bacterial growth before inoculation of eggs with sporozoites or during experimentation. Between 0-72 h after inoculation, the mean chicken mortality was 7%; post mortem examination of dead embryos indicated trauma due to needle damage during inoculation (results not shown). Between 96-168 h after inoculation, the mean embryo mortality was 4%. Examination of dead embryos at 120 h after inoculation showed chorioallantoic haemorrhage (the allantoic fluid being dark red), which was interpreted to represent damage due to the asexual replication (schizogony) of the parasite. For all seven experiments, the mean oocyst yield was 169,000 oocysts per egg (with a mean mortality of 11.1% for a period of 168 h). Sporozoites from oocysts produced in egg embryos (stored for 28 days) were used to inoculate 34 eggs (at a dose of 8,800 sporozoites per egg). None of the embryos died during the entire experimental period of 168 h, and the yield and reproductive index were 22,000 and 20 oocysts per egg, respectively. Sporozoites from this passage were also successfully passaged again in eggs (results not shown).
Oocysts representing E. tenella Rt3+15 were propagated in embryonating chicken eggs after inoculation with 2,600 to 8,700 sporozoites (per egg), achieving yields of 16,000-360,000 oocysts per egg after 7 days. Eggs were rotated after inoculation, with the rationale of achieving an even distribution of the sporozoite inoculum and minimizing the high levels of embryo mortality recorded in preliminary studies when eggs were not rotated. Mortality in embryos in eggs not rotated showed extensive haemorrhage in the chorioallantoic membranes. Hence, current evidence suggests that egg rotation achieves improved reproduction in the chorioallantoic membranes. Further experiments should compare the effects of different types/speeds of egg rotation on embryo mortality and on the reproductive index for E. tenella Rt3+15. A subsequent observation has been that the inoculation of sporozoites into the opposite end of the air sac of 18-day-old embryos (aimed to penetrate the yolk sac just prior to its withdrawal into the abdominal cavity) did not result in any significant mortality (Richards, unpublished observation). Hence, the age of the embryo and its ability to withstand trauma and/or the site of injection of sporozoites are considered central to achieving the best reproductive rates.
Eimeria tenella Rt3+15 is presently being used as an effective vaccine at a dose rate of 150 oocysts per chicken. With the mean inoculation dose of 7,500 sporozoites, one chicken egg can produce 1,250 doses of vaccine. This equates to 800 eggs per one million vaccine doses. However, compared with the reproductive index (5,600) of this line of E. tenella in chickens (unpublished data), the propagation in eggs is presently less efficient and yields are variable. In the present study, there was considerable variation in the oocyst yields among experiments, although the yields within an experiment among individual embryos did not vary greatly (data not shown). Nonetheless, it should be possible to achieve higher oocyst yields and enhanced embryo-adaptation (leading to decreased embryonic mortality) through increased serial passage in eggs, thereby maintaining immunogenicity in the vaccinated host. For instance (using an inoculation dose of 10,000 sporozoites per egg), Long (1972) reported embryonic mortalities of 29, 7 and 0% during passages 1, 37 and 38, respectively. The corresponding reproductive indices were 500, 1,800 and 1,300 from respective passages. It is likely that the lower reproductive indices achieved in the present study compared with that of Long (1972) relate to an insufficient adaptation to the growth in chicken embryo and precocious nature of Rt3+15 E. tenella line. Further experimentation is required to verify whether the pathogenicity and/or immunogenicity of E. tenella Rt3+15 in chickens change as it adapts to chicken embryos over a large number of passages and to establish its reproductive characteristics in embryos and, subsequently, in chickens. Since the serial passage of E. tenella in embryonating chicken eggs commonly results in the emergence of a line significantly less pathogenic in chickens compared with 'field strains' but immunogenic (Long et al. 1982) , an embryo-adapted line (after more than 100 passages) has been incorporated into the Livacox ® vaccine (Shirley and Bedrnik 1997) . Eimeria tenella Rt3+15 has the potential to cause moderate caecal lesions in young chickens (Richards, unpublished). Thus, a reduction in its pathogenicity and increase in its reproductive index during chicken embryo-adaptation are likely to enhance its suitability as a vaccine constituent, but these aspects require testing.
The propagation of E. tenella Rt3+15 in embryonated chicken eggs may also have implications for fundamental investigations of the developmental biology of this parasite, the parasite-host relationship and, importantly, for investigating the molecular biology of reproduction and development. This 'closed' experimental system (i.e. the chicken embryo) could provide opportunities for functional genomic studies of E. tenella, having advantages over the use of chickens. This is particularly pertinent given the Eimeria genome projects presently underway (Shirley et al. 2004) . For example, it may be possible to establish and subsequently utilize doublestranded RNA interference (RNAi or gene silencing) (cf. Campbell and Choy 2005) to investigate the functions of specific genes in E. tenella in ovo. There are a number of reports of the applicability of RNAi to protozoan parasites (Ullu et al. 2004) , including apicomplexans, although there is some debate as to whether Plasmodium species have the genetic make-up or machinery for gene-silencing. Given that the in vitro propagation of Eimeria has major limitations compared with the in vivo propagation in chicken embryos, there appears to be scope for developing a gene-silencing tool for E. tenella, provided that this species has the appropriate molecular machinery. Hence, while some improvements need to be made to the propagation approach for the production of 158 Stanis³a Precocious vaccine against E. tenella E. tenella Rt3+15 in chicken embryos, it has the potential to lead to the development of a functional genomic tool.
